Introducing Plakrim Kaitao, a groundbreaking AAAA-grade cannabis strain that emerged from Thailand's fertile landscapes. This innovative strain is the result of a unique cross between Jungle Lava and Colt 45, meticulously developed over eight months by the esteemed breeder, Plakrim. Released on February 9th, 2024, Plakrim Kaitao is a testament to Thailand's burgeoning prowess in cannabis genetics, boasting a 65% Indica and 35% Sativa composition with a potent THC of 23%.

Unlike traditional strains, Plakrim Kaitao was not a product of collaboration but a solo endeavor by Plakrim, showcasing his dedication to creating a strain with unparalleled potency and a balanced high. This strain is the first of its kind, marking a significant milestone in the cannabis industry, especially within Thailand, highlighting the country's capacity to produce top-tier cannabis strains.

The essence of Plakrim Kaitao is captured not only in its potent effects but also in its complex aroma and flavor profile. Expect a rich tapestry of scents and tastes, combining earthy undertones with sweet and spicy notes that reflect its exotic genetic heritage. The strain's effects are as nuanced as its flavors, beginning with a cerebral uplift from its Sativa components that stimulate creativity and elevate mood. This is seamlessly complemented by the calming, soothing influence of its Indica genetics, offering a deeply relaxing experience ideal for evening use or stress relief.

Cultivation of Plakrim Kaitao is a labor of love, with each bud reflecting the strain's superior quality and the meticulous care taken during its development. This strain's extended cultivation period is a hallmark of its exceptional quality, ensuring that each bud delivers the maximum potency and therapeutic benefits.

Plakrim Kaitao stands as a symbol of innovation and excellence in cannabis breeding, offering users a harmonious blend of mental invigoration and physical relaxation. It is especially noted for its medicinal potential, providing relief from conditions such as chronic pain, stress, and insomnia.